Find an expert
Our panel of editors are available for interview
Professor Yu-Chuan Jack Li
Editor-in-Chief of BMJ Health & Care Informatics
Professor Yu-Chuan Jack Li is a researcher of artificial intelligence in medicine and medical informatics, and a practising dermatologist. He is currently Dean and distinguished professor at the College of Medical Science and Technology, Taipei Medical University and the Chief of Dermatology at the Centre for Cosmetic and Laser, Paipei Municipal Wanfang Hospital. Professor Li has also served as President of the Asia-Pacific Association for Medical Informatics (APAMI), and President-elect of International Medical Informatics Association (IMIA).
Dr Declan Walsh
Editor-in-Chief of BMJ Supportive & Palliative Care
A pioneer in palliative medicine, Dr Declan Walsh is an internationally renowned physician, researcher, educator and administrator. He developed the first palliative care programme in the United States. In recognition of his achievements, he received the John Mendelsohn Award from MD Anderson Cancer Centre, a lifetime achievement award from the Multinational Association for Supportive Care in Cancer and a Visionary Award from the American Academy of Hospice and Palliative Medicine.
Dr Ellen Weber
Editor-in-Chief of Emergency Medicine Journal
Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
